PulseSelect
Stories
-
Medtronic reports positive real-world registry results for Sphere-9 and PulseSelect at APHRS 2026
Medtronic said the APEX registry included 1,050 patients with atrial fibrillation treated with the Sphere-9 catheter, reporting a 1.1% major complication rate. The REAL PULSE registry included 1,160 patients and reported a 100% acute success rate with a 0.09% acute major complication rate.